Orphenadrine Citrate
NDC Package 68788-9306-2
Package Information
Orphenadrine Citrate is orphenadrine is used to treat muscle spasms/pain. Marketed by Preferred Pharmaceuticals, Inc., this product is identified by NDC 68788-9306 and is authorized under FDA application ANDA040327.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 68788 - Preferred Pharmaceuticals, Inc.
- 68788-9306 - Orphenadrine Citrate
- 68788-9306-2 - 20 TABLET, EXTENDED RELEASE in 1 BOTTLE
- 68788-9306 - Orphenadrine Citrate
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (68788-9306). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 68788-9306-2 identifies a specific commercial package of 20 tablet, extended release in 1 bottle of Orphenadrine Citrate, labeled by Preferred Pharmaceuticals, Inc.. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Preferred Pharmaceuticals, Inc. on February 15, 2000. The current certification is valid through November 08, 2019.
What are the primary indications for this medication?
Orphenadrine is used to treat muscle spasms/pain. It is usually used along with rest, physical therapy, and other treatment.
How is this Preferred Pharmaceuticals, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 68788930602. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.
